Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2448-2452

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torzewski, M.
Right arrow Articles by Gabbert, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torzewski, M.
Right arrow Articles by Gabbert, H. E.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2448-2452.)
© 1997 American Heart Association, Inc.


Articles

Immunohistochemical Colocalization of the Terminal Complex of Human Complement and Smooth Muscle Cell {alpha}-Actin in Early Atherosclerotic Lesions

Michael Torzewski; Jan Torzewski; David E. Bowyer; Johannes Waltenberger; Colin Fitzsimmons; Vinzenz Hombach; ; Helmut E. Gabbert

From the Institute of Pathology, Heinrich-Heine-University Düsseldorf, Germany, and the Department of Cardiology, University of Ulm, Germany (J.T., J.W., V.H.), and the Department of Pathology, University of Cambridge, Cambridge, UK (D.E.B., C.F.)

Correspondence to Dr David Bowyer, University of Cambridge, Department of Pathology, Division of Cellular Pathology, Tennis Court Road, Cambridge CB2 1QP, England. E-mail david.bowyer{at}mole.bio.cam.ac.uk.

Abstract There is substantial evidence that activated components of the complement cascade are present in atherosclerotic lesions, and it was suggested some years ago that smooth muscle cells may be an important target of complement attack by the terminal components of the cascade, C5b-9, also called the membrane attack complex. Recent in vitro studies have shown that assembly of membrane attack complex on smooth muscle cells leads to the release of monocyte chemotactic protein-1, and, if this were to occur in vivo, then it could be responsible for the recruitment of monocytes into the lesion. In this study we have investigated the localization of C5b-9 in early atherosclerotic lesions of human coronary arteries, collected from autopsies, by immunohistochemical staining. C5b-9 was found to colocalize widely with smooth muscle cell {alpha}-actin, but not with intact macrophages, thus supporting the hypothesis that interaction of complement with smooth muscle cells may indeed be important in atherogenesis.


Key Words: atherogenesis • C5b-9 • early lesions • complement




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. R. Kinderlerer, F. Ali, M. Johns, E. A. Lidington, V. Leung, J. J. Boyle, S. S. Hamdulay, P. C. Evans, D. O. Haskard, and J. C. Mason
KLF2-dependent, Shear Stress-induced Expression of CD59: A NOVEL CYTOPROTECTIVE MECHANISM AGAINST COMPLEMENT-MEDIATED INJURY IN THE VASCULATURE
J. Biol. Chem., May 23, 2008; 283(21): 14636 - 14644.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. K. Bhatia, S. Yun, V. Leung, D. C. Grimsditch, G. M. Benson, M. B. Botto, J. J. Boyle, and D. O. Haskard
Complement C1q Reduces Early Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
Am. J. Pathol., January 1, 2007; 170(1): 416 - 426.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. A. Lidington, R. Steinberg, A. R. Kinderlerer, R. C. Landis, M. Ohba, A. Samarel, D. O. Haskard, and J. C. Mason
A role for proteinase-activated receptor 2 and PKC-{epsilon} in thrombin-mediated induction of decay-accelerating factor on human endothelial cells
Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1437 - C1447.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
T. Matsunaga and M.-a. Muramatsu
Knowledge-based computational search for genes associated with the metabolic syndrome
Bioinformatics, July 15, 2005; 21(14): 3146 - 3154.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Rus and F. Niculescu
Association of Complement Inhibitors With Connective Tissue Matrix in Atherosclerotic Lesions
Arterioscler Thromb Vasc Biol, August 1, 2003; 23(8): 1478 - 1478.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Oksjoki, H. Jarva, P. T. Kovanen, P. Laine, S. Meri, and M. O. Pentikainen
Association Between Complement Factor H and Proteoglycans in Early Human Coronary Atherosclerotic Lesions: Implications for Local Regulation of Complement Activation
Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 630 - 636.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Dimayuga, B. Cercek, S. Oguchi, G. N. Fredrikson, J. Yano, P. K. Shah, S. Jovinge, and J. Nilsson
Inhibitory Effect on Arterial Injury-Induced Neointimal Formation by Adoptive B-Cell Transfer in Rag-1 Knockout Mice
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 644 - 649.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. A. Lidington, D. O. Haskard, and J. C. Mason
Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury
Blood, October 15, 2000; 96(8): 2784 - 2792.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Orlandi, M. Marcellini, and L. G. Spagnoli
Aging Influences Development and Progression of Early Aortic Atherosclerotic Lesions in Cholesterol-Fed Rabbits
Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1123 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. D. Collard, A. Agah, W. Reenstra, J. Buras, and G. L. Stahl
Endothelial Nuclear Factor-{kappa}B Translocation and Vascular Cell Adhesion Molecule-1 Induction by Complement : Inhibition With Anti-Human C5 Therapy or cGMP Analogues
Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2623 - 2629.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. C. Mason, H. Yarwood, K. Sugars, B. P. Morgan, K. A. Davies, and D. O. Haskard
Induction of Decay-Accelerating Factor by Cytokines or the Membrane-Attack Complex Protects Vascular Endothelial Cells Against Complement Deposition
Blood, September 1, 1999; 94(5): 1673 - 1682.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Torzewski, M. Torzewski, D. E. Bowyer, M. Frohlich, W. Koenig, J. Waltenberger, C. Fitzsimmons, and V. Hombach
C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries
Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1386 - 1392.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Torzewski, M. Klouche, J. Hock, M. Meßner, B. Dorweiler, J. Torzewski, H. E. Gabbert, and S. Bhakdi
Immunohistochemical Demonstration of Enzymatically Modified Human LDL and Its Colocalization With the Terminal Complement Complex in the Early Atherosclerotic Lesion
Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 369 - 378.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Dimayuga, B. Cercek, S. Oguchi, G. N. Fredrikson, J. Yano, P. K. Shah, S. Jovinge, and J. Nilsson
Inhibitory Effect on Arterial Injury-Induced Neointimal Formation by Adoptive B-Cell Transfer in Rag-1 Knockout Mice
Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 644 - 649.
[Abstract] [Full Text] [PDF]